Helius Medical Technologies, Inc. (HSDT)
Stock Price:
$0.535 USD
-0.020 (-3.68%)
Updated Aug 3, 2020 12:46 PM EDT - Market open
Key Info
| Market Cap |
20.34M |
| Revenue (ttm) |
1.03M |
| Net Income (ttm) |
-15.86M |
| Shares Out |
38.04M |
| EPS (ttm) |
-0.57 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Aug 3, 2020 |
| Last Price |
$0.535 |
| Previous Close |
$0.555 |
| Change ($) |
-0.020 |
| Change (%) |
-3.68% |
| Day's Open |
0.540 |
| Day's Range |
0.524 - 0.560 |
| Day's Volume |
223,025 |
| 52-Week Range |
0.249 - 2.350 |
More Stats
| Market Cap |
20.34M |
| Enterprise Value |
16.57M |
| Earnings Date (est) |
Aug 6, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
38.04M |
| Float |
30.92M |
| EPS (basic) |
-0.58 |
| EPS (diluted) |
-0.57 |
| FCF / Share |
-0.59 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
940,522 |
| Short Ratio |
1.49 |
| Short % of Float |
3.10% |
| Beta |
0.94 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
19.82 |
| PB Ratio |
3.96 |
| Revenue |
1.03M |
| Operating Income |
-21.18M |
| Net Income |
-15.86M |
| Free Cash Flow |
-18.15M |
| Net Cash |
3.76M |
| Net Cash / Share |
0.10 |
| Gross Margin |
63.35% |
| Operating Margin |
-2,064.04% |
| Profit Margin |
-1,544.50% |
| FCF Margin |
-1,769.20% |
| ROA |
-84.40% |
| ROE |
-184.15% |
| ROIC |
-4,766.90% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (1)
| Buy |
0 |
| Overweight |
0 |
| Hold |
1 |
| Underweight |
0 |
| Sell |
0 |
Low
10.0
Current: $0.535
High
10.0
Target: 10.00
*Average 12-month price target from 1 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 |
|---|
| Revenue | 1.50 | 0.48 | - | - | - | - |
| Revenue Growth | 212.97% | - | - | - | - | - |
| Gross Profit | 0.65 | 0.48 | - | - | - | - |
| Operating Income | -24.00 | -26.68 | -22.85 | -9.32 | -9.81 | -1.07 |
| Net Income | -9.78 | -28.62 | -28.02 | -6.88 | -9.84 | -1.07 |
| Shares Outstanding | 26.35 | 22.79 | 18.63 | 13.30 | 11.41 | 6.41 |
| Earnings Per Share | -0.37 | -1.26 | -1.50 | -0.60 | -0.85 | -0.15 |
| Operating Cash Flow | -21.00 | -19.62 | -19.33 | -7.94 | -6.32 | -0.35 |
| Capital Expenditures | -0.35 | -0.44 | -0.19 | - | - | - |
| Free Cash Flow | -21.35 | -20.06 | -19.52 | -7.94 | -6.32 | -0.35 |
| Cash & Equivalents | 5.46 | 25.58 | 5.56 | 2.64 | 0.80 | 0.02 |
| Total Debt | 0.64 | - | - | - | - | 0.37 |
| Net Cash / Debt | 4.82 | 25.58 | 5.56 | 2.64 | 0.80 | -0.35 |
| Assets | 10.35 | 27.83 | 6.81 | 4.04 | 1.22 | 0.32 |
| Liabilities | 4.51 | 17.97 | 14.30 | 4.06 | 2.78 | 0.58 |
| Book Value | 5.84 | 9.85 | -7.49 | -0.02 | -1.56 | -0.27 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Helius Medical Technologies, Inc. |
| Country |
United States |
| Employees |
19 |
| CEO |
Philippe Deschamps |
Stock Information
| Ticker Symbol |
HSDT |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
NASDAQ: HSDT |
Description
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator (PoNS), a medical device in Canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. The company is headquartered in Newtown, Pennsylvania.